Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q1 2020 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Jul 23, 2019 / 01:00PM GMT
Release Date Price: ₹733.9 (-2.20%)
Operator

Ladies and gentlemen, good day and welcome to Torrent Pharmaceuticals Limited Q1 FY 2019-'20 Earnings Conference Call. We have with us today Mr. Aman Mehta, Chief Marketing Officer for India Business; Mr. Sanjay Gupta, Executive Director for International Business; and Mr. Sudhir Menon, Chief Financial Officer. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sanjay Gupta. Thank you, and over to you, sir.

Sanjay Gupta
Torrent Pharmaceuticals Limited - Executive Director of International Business

Good evening, everyone, and welcome to the Q1 FY '20 earnings call. I would like to begin by introducing to you Mr. Aman Mehta. He has been with the Torrent group for a period close to 5 years and has recently taken over as Chief Marketing Officer for our India business. And you will hear more from him this quarter and in the quarters going forward.

So coming back to our results. In Q1, our revenues were INR 2,022 crores, up by 8% on a year-over-year basis. Q1 EBITDA was INR 558 crores,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot